CVA, DVA, FVA, MVA, KVA — computed across rates, FX, credit, equities, and commodities. Full AAD Greeks. Exposure profiles. Counterparty risk. Collateral optimisation. Built by someone who ran this desk.
Gamma Quant computes the complete XVA stack — not just CVA in isolation, but the full interplay between adjustments, collateral, and funding.
Bump-and-reprice Delta ladders for a large derivatives book take hours. Gamma Quant uses Automatic Adjoint Differentiation (AAD via PyTorch) to compute all sensitivities in a single forward pass.
You can run the number but you can't inspect the model. Every Gamma Quant output shows its assumptions, calibration inputs, and model limitations — always.
Most XVA tools cover rates. Gamma Quant covers rates, FX, credit, equities, and commodities from day one, in a unified framework.
Enterprise licences for XVA tools run to six figures. Gamma Quant starts from £450/month for a desk licence — and from £59/month for individual analysts.
Monte Carlo simulation of exposure profiles (EPE, ENE, PFE) under risk-neutral and real-world measures. Netting set aware. CSA-compliant margining. Configurable simulation paths from 1,000 to 100,000.
CVA/DVA with bilateral or unilateral treatment. FVA with configurable funding curve. MVA computed over the MPOR. KVA under SA-CCR or internal model. All adjustments computed consistently off the same simulation.
Years on live XVA desks at HSBC and AXA
Asset classes — rates, FX, credit, equities, commodities
Per month for institutional desk licence — from
Automatic Adjoint Differentiation — all Greeks in one pass, not bump-reprice
"I ran XVA at HSBC. I know what a production system needs to do — and I know where vendor tools fall short. Gamma Quant is the tool I wanted to have."Youssouf Kerzika, Founder — XVA Rates & FX, HSBC · Insurance Risk, AXA
Institutional pricing starts from £450/month. We'll walk you through the models, show you the source assumptions, and scope the integration to your data infrastructure.
Book a callGlobal Gamma outputs are for informational and research purposes only. They do not constitute financial advice, investment recommendations, or regulated services. Global Gamma Ltd is not authorised by the FCA. Always seek independent professional advice before making financial decisions.